Despite many successful pilots and deployments of remote patient monitoring technologies, the healthcare industry has yet to experience a “gold standard trial” that stakeholders can universally point to as a proof of concept demonstrating its clinical value.

So argues Victor Camlek, transformational health industry principal at research firm Frost & Sullivan, who forecasts a compound annual growth rate of 13.2 percent through 2020 for the U.S. remote patient monitoring market.

Register or login for access to this item and much more

All Health Data Management content is archived after seven days.

Community members receive:
  • All recent and archived articles
  • Conference offers and updates
  • A full menu of enewsletter options
  • Web seminars, white papers, ebooks

Don't have an account? Register for Free Unlimited Access